Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: A population-based descriptive study in the European region with the highest incidence

Melanoma Research

Volumn 23, Issue 5, 2013, Pages 402-407

  Bordoni, Andrea ^a   Leoni Parvex, Sandra ^a   Peverelli, Simona ^a   Mazzola, Paola ^a   Mazzucchelli, Luca ^a   Spitale, Alessandra ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Breslow thickness; Cancer registry; Histological type; Incidence trend; Melanoma; Mortality trend; Opportunistic screening

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CUTANEOUS MELANOMA; DESCRIPTIVE RESEARCH; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SECONDARY PREVENTION; SWITZERLAND; EARLY DIAGNOSIS; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REGISTER; RISK FACTOR; SKIN NEOPLASMS; TIME; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; SKIN NEOPLASMS; SWITZERLAND; TIME FACTORS; YOUNG ADULT;

EID: 84888006051     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328363b015     Document Type: Article

References (27)

1. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007.
2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10. Lyon: IARC; 2008.
3. Bordoni A, Spitale A, Mazzola P. Registro cantonale dei tumori; 2011. Available at: http://www.ti.ch/cancer. [Accessed 1 May 2013].
4. Wyss N, Roy E. Epidemiology of melanoma. Neuchatel: Federal Office of Statistic; 2012.
5. Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol 2012; 23:524-530.
6. Crocetti E, Caldarella A, Chiarugi A, Nardini P, Zappa M. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past. Melanoma Res 2010; 20:422-426.
7. Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream? Br J Dermatol 2009; 161:630-634.
8. Montella A, Gavin A, Middleton R, Autier P, Boniol M. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. Eur J Cancer 2009; 45:2360-2366.
9. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration. Principles and methods. IARC Scientific Publication No. 95. Lyon: IARC; 1991.
10. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon: IARC; 2004.
11. Tyczynski JE, Démaret E, Parkin DM. Standards and guidelines for cancer registration in Europe. The ENCR recommendations, Vol. I. IARC Technical Publication No.40. Lyon: IARC; 2003.
12. Ferlay J, Burkhard C, Whelan S, Parkin DM. Check and conversion programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42. Lyon: IARC; 2005.
13. Bullard J, Coleman MP, Robinson D, Lutz JM, Bell J, Peto J. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000; 82:1111-1116.
14. Montanaro F, Robinson D, Bordoni A, Lutz JM. A modification to the flow method to estimate completeness in cancer registries with delayed registration. J Public Health (Oxf) 2006; 28:274-277.
15. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
16. LeBoit PE, Burg G, Weedon D, Sarasin A. Pathology and genetics of skin tumours. Lyon: IARC; 2006.
17. Wagner G. Tumor-Lokalisationsschlüssel. International Classification of Diseases for Oncology ICD-O, 2. Topographischer Teil. 5th ed. Berlin: Springer-Verlag; 1993.
18. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
19. Swiss Federal Office of Statistics. Cause of death statistics. Available at: http://www.bfs.admin.ch. [Accessed 1 May 2013].
20. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research, Vol. 4. Lyon: IARC Scientific Publications, World Health Organisation; 1994.
21. Armitage P, Berry G, JNS Matthews. Statistical methods in medical research. 4th ed. Oxford: Blackwell Science Ltd; 2002.
22. Van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47:483-489.
23. De Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40:2355-2366.
24. Luke CG, Coventry BJ, Foster-Smith EJ, Roder DM. A critical analysis of reasons for improved survival from invasive cutaneous melanoma. Cancer Causes Control 2003; 14:871-878.
25. Levi F, Te VC, Randimbison L, La Vecchia C. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res 2005; 15:73-75.
26. Kruijff S, Bastiaannet E, Francken AB, Schaapveld M, van der Aa M, Hoekstra HJ. Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients. Br J Cancer 2012; 107:570-574.
27. De Vries E, Bray FI, Eggermont AM, Coebergh JW. Monitoring stagespecific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev 2004; 13:387-395.